Adma Biologics (ADMA) Enterprise Value (2011 - 2025)
Adma Biologics (ADMA) posted Enterprise Value of -$87.6 million for Q4 2025, down 42.75% on a QoQ basis from -$61.4 million in Q3 2025, and up 15.04% year-over-year from -$76.2 million in Q4 2024.
Adma Biologics (ADMA) Enterprise Value (2011 - 2025) Analysis & Trends
Adma Biologics' Enterprise Value history runs 15 years deep, the most recent figure standing at -$87.6 million for Q4 2025.
- Quarterly Enterprise Value rose 15.04% year-over-year to -$87.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$87.6 million (up 15.04% YoY) and the FY2025 annual result came in at -$87.6 million, up 15.04% from the prior year.
- Enterprise Value was -$87.6 million for Q4 2025 at Adma Biologics, down from -$61.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$34.4 million in Q3 2021 and bottomed at -$103.1 million in Q4 2024.
- A 5-year average of -$66.2 million and a median of -$65.9 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value surged 42.35% — and 2023, when it slumped 112.57%.
- Adma Biologics' Enterprise Value stood at -$51.1 million in 2021, then sank by 69.36% to -$86.5 million in 2022, then surged by 40.65% to -$51.4 million in 2023, then tumbled by 100.86% to -$103.1 million in 2024, then gained by 15.04% to -$87.6 million in 2025.
- Business Quant data shows ADMA's Enterprise Value at -$87.6 million in Q4 2025, -$61.4 million in Q3 2025, and -$90.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -87.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -87.63 Mn |
| Sep 30, 2025 | -61.39 Mn |
| Jun 30, 2025 | -90.29 Mn |
| Mar 31, 2025 | -71.63 Mn |
| Dec 31, 2024 | -103.15 Mn |
| Sep 30, 2024 | -86.70 Mn |
| Jun 30, 2024 | -88.20 Mn |
| Mar 31, 2024 | -45.30 Mn |
| Dec 31, 2023 | -51.35 Mn |
| Sep 30, 2023 | -74.20 Mn |
| Jun 30, 2023 | -62.51 Mn |
| Mar 31, 2023 | -69.20 Mn |
| Dec 31, 2022 | -86.52 Mn |
| Sep 30, 2022 | -34.91 Mn |
| Jun 30, 2022 | -52.42 Mn |
| Mar 31, 2022 | -69.50 Mn |
| Dec 31, 2021 | -51.09 Mn |
| Sep 30, 2021 | -34.40 Mn |
| Jun 30, 2021 | -42.41 Mn |
| Mar 31, 2021 | -61.97 Mn |